This became a reality for my family when my daughter, Natalie, went from being a picture of health to being told in the hospital she had Crohn's disease at age 21. The first in our family to be ...

Natalie Hayden was a young adult when she was diagnosed with Crohn's disease. Her mom once again became her caregiver.

Intestinal ultrasound (IUS) responses were assessed ... Italy and principal investigator, said: “Crohn's disease patients may respond to treatment while continuing to experience internal ...

MedStar Georgetown University Hospital is the first hospital in the Washington, D.C. region to offer bedside intestinal ...

D.C. region to offer bedside intestinal ultrasound (IUS) to monitor inflammation in IBD patients. To assess chronic inflammatory diseases of the intestines, like Crohn's disease and ulcerative ...

Researchers examined 377 pregnant individuals with IBD, more than half of whom had Crohn’s disease, recruited from three specialised IBD pregnancy clinics. Clinical assessments, FCP levels, and IUS ...

A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease, according to findings published in Science Immunology on March 21.

If you are a parent, then you probably first laid eyes on your child through an ultrasound procedure ... form in the brains of people with the disease, with the objective to increase both ...

Biologic medical therapies, or biologics, are an important type of treatment for Crohn’s disease and inflammatory bowel disease. Biologics are a wide-ranging class of drugs, and there are many ...

Tremfya is the only IL-23 inhibitor with IV and SC induction options for treating Crohn disease. The Food and Drug Administration (FDA) has approved Tremfya ® (guselkumab) for the treatment of adults ...

Image credit: Shutterstock/Buravleva stock. GE HealthCare’s newest offering from its automated ultrasound system line represents a significant advancement in breast cancer screening, according to ...

The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for adult patients with moderately to severely active Crohn disease. This approval is the fourth ...